// App-Quantinova.ai

Mo1532 : ADEQUATE DETERMINATION OF THE TRANSITION ZONE IN HIRSCHSPRUNG DISEASE AND THE ROLE OF CALRETININ STAINING IN CLINICAL PRACTICE

Researchers

Presenter

  • Dorothee Dal Soglio

Principal Investigators

  • Christophe Faure

  • Natalie Patey

Medical Centers

  • Department of pediatric gastroenterology, CHU Sainte Justine, Montreal, Quebec, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

Disease

  • N/A

Biomarkers

  • Protein Gene Product 9.5

Drug/Treatment

  • N/A

Outcome

  • Unknown


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim